PROCTER & GAMBLE HEALTH | VISTA PHARMA | PROCTER & GAMBLE HEALTH/ VISTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -7.6 | - | View Chart |
P/BV | x | 10.6 | 2.1 | 499.5% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH VISTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
VISTA PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ VISTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 14 | 37,235.3% | |
Low | Rs | 3,883 | 7 | 59,646.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 0.3 | 277,111.6% | |
Earnings per share (Unadj.) | Rs | 138.2 | -1.5 | -9,170.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -1.3 | -11,554.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 8.1 | 5,503.3% | |
Shares outstanding (eoy) | m | 16.60 | 37.56 | 44.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 39.1 | 16.0% | |
Avg P/E ratio | x | 33.5 | -6.9 | -482.1% | |
P/CF ratio (eoy) | x | 29.8 | -7.8 | -382.7% | |
Price / Book Value ratio | x | 10.3 | 1.3 | 803.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 393 | 19,539.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 5 | 40,504.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 10 | 122,472.1% | |
Other income | Rs m | 184 | 4 | 4,609.0% | |
Total revenues | Rs m | 12,480 | 14 | 88,953.0% | |
Gross profit | Rs m | 3,247 | -44 | -7,304.4% | |
Depreciation | Rs m | 281 | 6 | 4,546.9% | |
Interest | Rs m | 8 | 12 | 63.4% | |
Profit before tax | Rs m | 3,142 | -59 | -5,347.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -2 | -39,593.5% | |
Profit after tax | Rs m | 2,295 | -57 | -4,052.8% | |
Gross profit margin | % | 26.4 | -442.7 | -6.0% | |
Effective tax rate | % | 27.0 | 3.6 | 739.4% | |
Net profit margin | % | 18.7 | -563.9 | -3.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 238 | 4,931.5% | |
Current liabilities | Rs m | 6,791 | 141 | 4,822.3% | |
Net working cap to sales | % | 40.0 | 963.0 | 4.2% | |
Current ratio | x | 1.7 | 1.7 | 102.3% | |
Inventory Days | Days | 263 | 207 | 127.2% | |
Debtors Days | Days | 343 | 40,902 | 0.8% | |
Net fixed assets | Rs m | 10,617 | 296 | 3,582.6% | |
Share capital | Rs m | 166 | 75 | 221.0% | |
"Free" reserves | Rs m | 7,265 | 230 | 3,153.1% | |
Net worth | Rs m | 7,431 | 306 | 2,432.2% | |
Long term debt | Rs m | 0 | 52 | 0.0% | |
Total assets | Rs m | 22,330 | 534 | 4,182.7% | |
Interest coverage | x | 409.1 | -3.8 | -10,649.6% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0 | 2,928.1% | |
Return on assets | % | 10.3 | -8.3 | -123.7% | |
Return on equity | % | 30.9 | -18.5 | -166.6% | |
Return on capital | % | 42.4 | -13.1 | -324.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -17 | -13,793.1% | |
From Investments | Rs m | -215 | -13 | 1,692.9% | |
From Financial Activity | Rs m | -985 | 31 | -3,162.2% | |
Net Cashflow | Rs m | 1,160 | 1 | 87,901.5% |
Indian Promoters | % | 0.0 | 19.9 | - | |
Foreign collaborators | % | 51.8 | 15.5 | 333.9% | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 49,925.0% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 64.6 | 74.6% | |
Shareholders | 56,778 | 13,846 | 410.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | VISTA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.31% | 0.45% |
1-Month | -1.15% | 20.62% | 2.55% |
1-Year | 0.73% | 37.77% | 56.14% |
3-Year CAGR | -8.76% | -2.25% | 15.22% |
5-Year CAGR | 4.97% | -6.01% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the VISTA PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of VISTA PHARMA the stake stands at 35.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of VISTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
VISTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of VISTA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.